Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 11—November 2003
Dispatch

Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia

Leanne Unicomb*Comments to Author , John Ferguson†, Thomas V Riley‡, and Peter Collignon§
Author affiliations: *OzFoodNet, Newcastle, Australia; †University of Newcastle, Newcastle, Australia; ‡Western Australian Centre for Pathology & Medical Research, Perth, Australia; §The Canberra Hospital, Garran, Australia

Main Article

Table

Fluoroquinolone resistance data for Australian Campylobacter isolates

Study location Isolate source and collection period Total no. tested Proportiona of fluoroquinolone-resistant isolates (%)
Locally acquired Overseas acquired Unknown acquisition status
New South Wales
 Human feces
1999–2001
 180b
 0/144 (0)
 3c/7 (43)
 2c/29 (6.9)
Western Australia
 Human feces
1999–2000
 50b
4c
 0/46 (0)
Australian Capital Territory Human feces/blood 2001–2002 140d 3 0/137 (0)

aNo. of resistant isolates by acquisition status/total no. isolates tested in acquisition status category.
bTesting by agar dilution, Mueller-Hinton agar with 5% lysed sheep blood (7).
cResistant to ciprofloxacin (MIC > 4 mg/L).
dTesting by disc-susceptibility method (8)..

Main Article

References
  1. Blumer  C, Roche  P, Spencer  J, Lin  M, Milton  A, Bunn  C, Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell. 2003;27:1–78.PubMedGoogle Scholar
  2. Smith  KE, Besser  KM, Hedberg  CW, Leano  FT, Bender  JB, Wicklund  JH, Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. N Engl J Med. 1999;340:1525–32. DOIPubMedGoogle Scholar
  3. Wegener  HC. The consequences for food safety of the use of fluoroquinolones in food animals. N Engl J Med. 1999;340:1581–2. DOIPubMedGoogle Scholar
  4. Engberg  J, Aarestrup  FM, Taylor  DE, Garner-Smidt  P, Nachamkin  I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis. 2001;7:24–34. DOIPubMedGoogle Scholar
  5. Gaunt  PN, Piddock  LJ. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J Antimicrob Chemother. 1996;37:747–57. DOIPubMedGoogle Scholar
  6. Commonwealth of Australia. The use of antibiotics in food-producing animals: antibiotic resistant bacteria in animals and humans. Report of the Joint Expert Advisory Committee on Antibiotic Resistance (JETACAR). 1999 [accessed 2003 Feb]. Available from: URL: http://www.health.gov.au/pubs/jetacar.htm
  7. Sharma  H, Unicomb  L, Forbes  W, Djordjevic  S, Valcanis  M, Dalton  C, Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. Commun Dis Intell. 2003;27(Suppl):S80–8.PubMedGoogle Scholar
  8. Huysman  MB, Turnidge  JD. Disc susceptibility testing for thermophilic Campylobacters. Pathology. 1997;29:209–16. DOIPubMedGoogle Scholar

Main Article

Page created: January 21, 2011
Page updated: January 21, 2011
Page reviewed: January 21, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external